MoonLake Immunotherapeutics Share Price Today: Live Updates & Key Insights
MoonLake Immunotherapeutics share price today is $16.484, up -2.46%. The stock opened at $16.67 against the previous close of $16.68, with an intraday high of $16.735 and low of $16.04.
MoonLake Immunotherapeutics Share Price Chart
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics Share Price Performance
MoonLake Immunotherapeutics Institutional Holdings
MoonLake Immunotherapeutics Market Status
MoonLake Immunotherapeutics Fundamentals
Market Cap 1167.01 M
PB Ratio 3.8304
PE Ratio 0.0
Enterprise Value 848.04 M
Total Assets 424.43 M
Volume 682635
MoonLake Immunotherapeutics Company Financials
About MoonLake Immunotherapeutics & investment objective
Company Information MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Organisation Biotechnology
Employees 130
Industry Biotechnology
CEO Dr. Jorge Santos da Silva Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
MoonLake Immunotherapeutics FAQs
What is the share price of MoonLake Immunotherapeutics today?
The current share price of MoonLake Immunotherapeutics is $16.484.
Can I buy MoonLake Immunotherapeutics shares in India?
Yes, Indian investors can buy MoonLake Immunotherapeutics shares by opening an international trading and demat account with Motilal Oswal.
How to buy MoonLake Immunotherapeutics shares in India?
You can easily invest in MoonLake Immunotherapeutics shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy MoonLake Immunotherapeutics shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of MoonLake Immunotherapeutics.
Can I buy fractional shares of MoonLake Immunotherapeutics?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics has a market cap of $1167.01 M.
In which sector does MoonLake Immunotherapeutics belong?
MoonLake Immunotherapeutics operates in the Biotechnology sector.
What documents are required to invest in MoonLake Immunotherapeutics stocks?
To invest, you typically need:
What is the PE and PB ratio of MoonLake Immunotherapeutics?
The PE ratio of MoonLake Immunotherapeutics is N/A and the PB ratio is 3.83.